ResMed Inc
Close on Nov 20, 2026Market cap $33.14BP/E 21.5Yield 1.02%
ResMed Free Cash Flow — Published Non-GAAP by Year
Free Cash Flow — Published Non-GAAP ($M) ($M)
ResMed Free Cash Flow — Published Non-GAAP: $1,650M in FY2026, down 0.7% from a year earlier.
Where the FY2026 figure comes from
“|| Free cash flow (C) | 1,650 | 1,662 | (1 | )”
Source: ResMed SEC Filing (0001193125-26-337962) ↗
Reported in ResMed Form 8-K Financial Results Summary & Quarterly Earnings Presentations.
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Free Cash Flow — Published Non-GAAP ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026CY2026 | Jun 30, 2026 | 1,650 | -0.7% | ResMed SEC Filing (0001193125-26-337962) ↗ |
| FY2025CY2025 | Jun 30, 2025 | 1,662 | +27.7% | ResMed SEC Filing (0001193125-26-337962) ↗ |
| FY2024CY2024 | Jun 30, 2024 | 1,302 | +127.0% | ResMed Q4 FY2025 Earnings Presentation (2025-07-31) ↗ |
| FY2023CY2023 | Jun 30, 2023 | 574 | +165.2% | ResMed Q4 FY2025 Earnings Presentation (2025-07-31) ↗ |
| FY2022CY2022 | Jun 30, 2022 | 216 | -65.9% | ResMed Q4 FY2022 Earnings Presentation (2022-08-11) ↗ |
| FY2021CY2021 | Jun 30, 2021 | 634 | -10.3% | ResMed Q4 FY2022 Earnings Presentation (2022-08-11) ↗ |
| FY2020CY2020 | Jun 30, 2020 | 707 | – | ResMed Q4 FY2022 Earnings Presentation (2022-08-11) ↗ |
Breakdown
What makes up free Cash Flow — Published Non-GAAP
Cite this data
StockData. (2026). ResMed Free Cash Flow — Published Non-GAAP ($M), annual FY2020–FY2026 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/fcf-published-m
See every metric in the ResMed KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?